← Browse by Condition
Medical Condition
idiopathic short stature
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT01604395
Recruiting
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
Enrollment
6,000 pts
Location
South Korea
Sponsor
LG Chem
NCT06927310 Phase 3
Recruiting
The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature
Enrollment
300 pts
Location
China
Sponsor
Xiamen Amoytop Biotech Co., Lt...